BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 20629596)

  • 1. CCR6 as a possible therapeutic target in psoriasis.
    Hedrick MN; Lonsdorf AS; Hwang ST; Farber JM
    Expert Opin Ther Targets; 2010 Sep; 14(9):911-22. PubMed ID: 20629596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CCL20 and CCR6 axis in psoriasis.
    Furue K; Ito T; Tsuji G; Nakahara T; Furue M
    Scand J Immunol; 2020 Mar; 91(3):e12846. PubMed ID: 31692008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-psoriasis effect of 18β-glycyrrhetinic acid by breaking CCL20/CCR6 axis through its vital active group targeting GUSB/ATF2 signaling.
    Wei J; Zhang J; Hu F; Zhang W; Wu Y; Liu B; Lu Y; Li L; Han L; Lu C
    Phytomedicine; 2024 Jun; 128():155524. PubMed ID: 38552435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein engineering of the chemokine CCL20 prevents psoriasiform dermatitis in an IL-23-dependent murine model.
    Getschman AE; Imai Y; Larsen O; Peterson FC; Wu X; Rosenkilde MM; Hwang ST; Volkman BF
    Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12460-12465. PubMed ID: 29109267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins inhibit chemotactic interaction between CCL20 and CCR6 in vitro: possible relevance to psoriasis treatment.
    Kim TG; Byamba D; Wu WH; Lee MG
    Exp Dermatol; 2011 Oct; 20(10):855-7. PubMed ID: 21824198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR6 is required for IL-23-induced psoriasis-like inflammation in mice.
    Hedrick MN; Lonsdorf AS; Shirakawa AK; Richard Lee CC; Liao F; Singh SP; Zhang HH; Grinberg A; Love PE; Hwang ST; Farber JM
    J Clin Invest; 2009 Aug; 119(8):2317-29. PubMed ID: 19662682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis.
    Homey B; Dieu-Nosjean MC; Wiesenborn A; Massacrier C; Pin JJ; Oldham E; Catron D; Buchanan ME; Müller A; deWaal Malefyt R; Deng G; Orozco R; Ruzicka T; Lehmann P; Lebecque S; Caux C; Zlotnik A
    J Immunol; 2000 Jun; 164(12):6621-32. PubMed ID: 10843722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of psoriasis by continuous neutrophil infiltration into the epidermis.
    Katayama H
    Exp Dermatol; 2018 Oct; 27(10):1084-1091. PubMed ID: 30019426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine receptors in the pathogenesis and therapy of psoriasis.
    Mabuchi T; Chang TW; Quinter S; Hwang ST
    J Dermatol Sci; 2012 Jan; 65(1):4-11. PubMed ID: 22177422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR6 is required for epidermal trafficking of γδ-T cells in an IL-23-induced model of psoriasiform dermatitis.
    Mabuchi T; Singh TP; Takekoshi T; Jia GF; Wu X; Kao MC; Weiss I; Farber JM; Hwang ST
    J Invest Dermatol; 2013 Jan; 133(1):164-71. PubMed ID: 22895364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCL20 Secretion from the Nucleus Pulposus Improves the Recruitment of CCR6-Expressing Th17 Cells to Degenerated IVD Tissues.
    Zhang W; Nie L; Wang Y; Wang XP; Zhao H; Dongol S; Maharjan S; Cheng L
    PLoS One; 2013; 8(6):e66286. PubMed ID: 23823618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis.
    Harper EG; Guo C; Rizzo H; Lillis JV; Kurtz SE; Skorcheva I; Purdy D; Fitch E; Iordanov M; Blauvelt A
    J Invest Dermatol; 2009 Sep; 129(9):2175-83. PubMed ID: 19295614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR6-CCL20 axis as a therapeutic target for autoimmune diseases.
    Meitei HT; Jadhav N; Lal G
    Autoimmun Rev; 2021 Jul; 20(7):102846. PubMed ID: 33971346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of CCL20 and recruitment of CCR6+ gastric infiltrating lymphocytes in Helicobacter pylori gastritis.
    Wu YY; Tsai HF; Lin WC; Hsu PI; Shun CT; Wu MS; Hsu PN
    Infect Immun; 2007 Sep; 75(9):4357-63. PubMed ID: 17562763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible expression of a CC chemokine liver- and activation-regulated chemokine (LARC)/macrophage inflammatory protein (MIP)-3 alpha/CCL20 by epidermal keratinocytes and its role in atopic dermatitis.
    Nakayama T; Fujisawa R; Yamada H; Horikawa T; Kawasaki H; Hieshima K; Izawa D; Fujiie S; Tezuka T; Yoshie O
    Int Immunol; 2001 Jan; 13(1):95-103. PubMed ID: 11133838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the CCR6/CCL20 Axis in Entheseal and Cutaneous Inflammation.
    Shi Z; Garcia-Melchor E; Wu X; Getschman AE; Nguyen M; Rowland DJ; Wilson M; Sunzini F; Akbar M; Huynh M; Law T; Raychaudhuri SK; Raychaudhuri SP; Volkman BF; Millar NL; Hwang ST
    Arthritis Rheumatol; 2021 Dec; 73(12):2271-2281. PubMed ID: 34081845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CC chemokine ligand 20 and CC chemokine receptor 6 mRNA in patients with psoriasis vulgaris.
    Wu Y; Li J
    J Huazhong Univ Sci Technolog Med Sci; 2004; 24(3):297-9. PubMed ID: 15315355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine receptor CCR6-dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis.
    Hammerich L; Bangen JM; Govaere O; Zimmermann HW; Gassler N; Huss S; Liedtke C; Prinz I; Lira SA; Luedde T; Roskams T; Trautwein C; Heymann F; Tacke F
    Hepatology; 2014 Feb; 59(2):630-42. PubMed ID: 23959575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CCL20-CCR6 Axis in Cancer Progression.
    Kadomoto S; Izumi K; Mizokami A
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma.
    Ikeda S; Kitadate A; Ito M; Abe F; Nara M; Watanabe A; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
    Oncotarget; 2016 Mar; 7(12):13563-74. PubMed ID: 26789110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.